Did you know recent data reveal that around half of patients with early breast cancer and detectable circulating tumor DNA showed metastases on staging scans?

Credit available for this activity expires: 1/15/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002143?ecd=bdc_podcast_libsyn_mscpedu

Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease?

Credit available for this activity expires: 1/29/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu

Tips from experts on how to achieve seizure freedom.

Credit available for this activity expires: 1/16/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002147?ecd=bdc_podcast_libsyn_mscpedu

Do you know how precision medicine is shaping the future of cancer care?

Credit available for this activity expires: 01/13/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-cancer-medicine-unveiling-future-2025a10000dr?ecd=bdc_podcast_libsyn_mscpedu

Do you know the latest data for weekly insulin in terms of efficacy and risk of hypoglycemia?

Credit available for this activity expires: 1/21/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002051?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on who is at risk for severe COVID-19 outcomes? Learn from our experts in this quickfire question-and-answer activity.

Credit available for this activity expires: 1/3/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002037?ecd=bdc_podcast_libsyn_mscpedu

Learn more on how to diagnose and manage patients with thyroid eye disease (TED).

Credit available for this activity expires: 12/20/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002025?ecd=bdc_podcast_libsyn_mscpedu

Discover key updates on emerging immunotherapy combinations in relapsed/refractory (R/R) follicular lymphoma (FL) from the hematology congress in San Diego.

Credit available for this activity expires: 12/18/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002061?ecd=bdc_podcast_libsyn_mscpedu